KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Non-cash Items (2019 - 2025)

Globus Medical (GMED) has disclosed Non-cash Items for 7 consecutive years, with $7.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 0.75% year-over-year to $7.4 million, compared with a TTM value of $7.4 million through Sep 2025, up 0.75%, and an annual FY2024 reading of $6.5 million, down 89.46% over the prior year.
  • Non-cash Items was $7.4 million for Q3 2025 at Globus Medical, up from $7.3 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $320.0 million in Q2 2021 and bottomed at $4.8 million in Q4 2021.
  • Average Non-cash Items over 5 years is $102.7 million, with a median of $61.8 million recorded in 2024.
  • Peak annual rise in Non-cash Items hit 5598.02% in 2021, while the deepest fall reached 97.96% in 2021.
  • Year by year, Non-cash Items stood at $4.8 million in 2021, then rose by 16.94% to $5.6 million in 2022, then skyrocketed by 1006.71% to $61.5 million in 2023, then plummeted by 89.46% to $6.5 million in 2024, then rose by 14.49% to $7.4 million in 2025.
  • Business Quant data shows Non-cash Items for GMED at $7.4 million in Q3 2025, $7.3 million in Q2 2025, and $186.1 million in Q1 2025.